Massachusetts Financial Services CO Lannett CO Inc Transaction History

Massachusetts Financial Services CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$4.9 - $7.12 $847,788 - $1.23 Million	-173,018 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$6.43 - $9.86 $28,362 - $43,492	-4,411 Reduced 2.49%	173,018 $1.26 Million
Q1 2020 May 14, 2020	BUY	$6.36 - $10.05 $178,620 - $282,254	28,085 Added 18.81%	177,429 $1.23 Million
Q4 2019 Feb 13, 2020	BUY	$8.49 - $12.81 $1.27 Million - $1.91 Million	149,344 New	149,344 $1.32 Million
Q3 2018 Oct 25, 2018	SELL	$4.75 - $14.5 $81,134 - $247,674	-17,081 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$13.3 - $17.45 $31,108 - $40,815	2,339 Added 15.87%	17,081 $233,000
Q1 2018 May 04, 2018	BUY	$14.7 - $24.95 $216,707 - $367,812	14,742 New	14,742 $237,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

Stay updated on Massachusetts Financial Services CO with notifications on news.